Larvol Delta - Acumen-Pharmaceuticals-to-Present-Patient-Experience-and-Biomarker-Insights-from-Phase-1-INTERCEPTAD-Study-at-the-Alzheimers-Association-International-Conference-AAIC-2024

sabirnetug IV (ACU193 IV) - Acumen Pharma

https://www.globenewswire.com/news-release/2024/07/11/2911782/0/en/Acumen-Pharmaceuticals-to-Present-Patient-Experience-and-Biomarker-Insights-from-Phase-1-INTERCEPT-AD-Study-at-the-Alzheimer-s-Association-International-Conference-AAIC-2024.html

Jul 11, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next